UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HIV at 40: kidney disease in HIV treatment, prevention, and cure

Kidney international, 2022-10, Vol.102 (4), p.740-749

2022

Volltextzugriff (PDF)

Kidney stones: KI at the crossroads of nephrology and urology

Kidney international, 2020-06, Vol.97 (6), p.1070-1073

Wyatt, Christina M.

2020

Volltextzugriff (PDF)

Manipulating the gut microbiome to decrease uremic toxins

Kidney international, 2017-03, Vol.91 (3), p.521-523

2017

Volltextzugriff (PDF)

Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected Adults

Clinical infectious diseases, 2015-02, Vol.60 (4), p.627-638

2015

Volltextzugriff (PDF)

Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?

Kidney international, 2016-04, Vol.89 (4), p.732-733

Wyatt, Christina M.

2016

Volltextzugriff (PDF)

The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy

Kidney international, 2014-08, Vol.86 (2), p.259-265

2014

Volltextzugriff (PDF)

A new BEACON of hope for the treatment of inflammation? The endogenous metabolite itaconate as an alternative activator of the KEAP1-Nrf2 system

Kidney international, 2018-10, Vol.94 (4), p.646-649

2018

Volltextzugriff (PDF)

Will a new tenofovir prodrug for the treatment of HIV reduce the risk of nephrotoxicity?

Kidney international, 2016-01, Vol.89 (1), p.5-6

Wyatt, Christina M.

2016

Volltextzugriff (PDF)

A rose by any other name: is stage 3a chronic kidney disease really a disease?

Kidney international, 2017-01, Vol.91 (1), p.6-8

Wyatt, Christina M.

2017

Volltextzugriff (PDF)

Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults

PloS one, 2012-07, Vol.7 (7), p.e40245

2012

Volltextzugriff (PDF)

REPRISE: tolvaptan in advanced polycystic kidney disease

Kidney international, 2018-02, Vol.93 (2), p.292-295

2018

Volltextzugriff (PDF)

Decreased incidence of end-stage renal disease in American Indians with diabetes: a model for other high-risk populations?

Kidney international, 2017-04, Vol.91 (4), p.766-768

Wyatt, Christina M.

2017

Volltextzugriff (PDF)

Stiripentol for the treatment of primary hyperoxaluria and calcium oxalate nephropathy

Kidney international, 2020-01, Vol.97 (1), p.17-19

2020

Volltextzugriff (PDF)

Removing race from GFR estimates: balancing potential benefits and unintended consequences

Kidney international, 2021-07, Vol.100 (1), p.11-13

2021

Volltextzugriff (PDF)

Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD

American journal of kidney diseases, 2018-02, Vol.71 (2), p.267-274

2018

Volltextzugriff (PDF)

Revisiting the determinants of the glomerular filtration barrier: what goes round must come round

Kidney international, 2017-09, Vol.92 (3), p.533-536

2017

Volltextzugriff (PDF)

The spectrum of kidney biopsy findings in HIV-infected patients in the modern era

Kidney international, 2020-05, Vol.97 (5), p.1006-1016

2020

Volltextzugriff (PDF)

Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults

Kidney international, 2018-06, Vol.93 (6), p.1260-1262

2018

Volltextzugriff (PDF)

Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease

Kidney international, 2016-04, Vol.89 (4), p.734-737

2016

Volltextzugriff (PDF)

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America

Clinical infectious diseases, 2014-11, Vol.59 (9), p.e96-e138

2014

Volltextzugriff (PDF)

The Bowman’s shield: a tribute to translational science and Detlef Schlöndorff

Kidney international, 2018-09, Vol.94 (3), p.448-450

2018

Volltextzugriff (PDF)

Vascular calcification in chronic kidney disease: here to stay?

Kidney international, 2017-08, Vol.92 (2), p.276-278

2017

Volltextzugriff (PDF)

Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease

Kidney international, 2020-04, Vol.97 (4), p.639-642

2020

Volltextzugriff (PDF)

Scratching the itch: a new therapeutic target for dialysis-associated pruritus?

Kidney international, 2020-03, Vol.97 (3), p.444-447

2020

Volltextzugriff (PDF)

Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals

AIDS (London), 2018-03, Vol.32 (6), p.739-749

2018

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(243)

Publikationsform

Sprache

Englisch
(294)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HIV at 40: kidney disease in HIV treatment, prevention, and cure

Kidney stones: KI at the crossroads of nephrology and urology

Manipulating the gut microbiome to decrease uremic toxins

Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected Adults

Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?

The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy

A new BEACON of hope for the treatment of inflammation? The endogenous metabolite itaconate as an alternative activator of the KEAP1-Nrf2 system

Will a new tenofovir prodrug for the treatment of HIV reduce the risk of nephrotoxicity?

A rose by any other name: is stage 3a chronic kidney disease really a disease?

Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults

REPRISE: tolvaptan in advanced polycystic kidney disease

Decreased incidence of end-stage renal disease in American Indians with diabetes: a model for other high-risk populations?

Stiripentol for the treatment of primary hyperoxaluria and calcium oxalate nephropathy

Removing race from GFR estimates: balancing potential benefits and unintended consequences

Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD

Revisiting the determinants of the glomerular filtration barrier: what goes round must come round

The spectrum of kidney biopsy findings in HIV-infected patients in the modern era

Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults

Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America

The Bowman’s shield: a tribute to translational science and Detlef Schlöndorff

Vascular calcification in chronic kidney disease: here to stay?

Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease

Scratching the itch: a new therapeutic target for dialysis-associated pruritus?

Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals

Suchergebnisse filtern